Epigenetic Modulation by Methionine Deficiency Attenuates the Potential for Gastric Cancer Cell Dissemination

Journal of Gastrointestinal Surgery

Volumn 17, Issue 1, 2013, Pages 39-49

  Graziosi, Luigina ^a   Mencarelli, Andrea ^b   Renga, Barbara ^b   D'Amore, Claudio ^b   Bruno, Angela ^b   Santorelli, Chiara ^a   Cavazzoni, Emanuel ^a   Cantarella, Francesco ^a   Rosati, Emanuele ^a   Donini, Annibale ^a   Fiorucci, Stefano ^b  

^a Nuova Facoltà di Medicina e Chirurgia   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Gastric cancer; Methionine and E cadherin; Peritoneal dissemination

Indexed keywords

EID: 84871944700     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-012-1996-1     Document Type: Article

References (29)

1. Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg. 2009; 96: 26-33.
2. Hoffman RM. Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochim Biophys Acta 1984; 738: 49-87.
3. Kenyon SH, Waterfield CJ, Timbrell JA, Nicolaou A. Methionine synthase activity and sulphur amino acid levels in the rat liver tumour cells HTC and Phi-1. Biochem Pharmacol 2002; 63: 381-391.
4. Mecham JO, Rowitch D, Wallace CD, Stern PH, Hoffman RM. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 1983; 117: 429-434.
5. Guo HY, Herrera H, Groce A, Hoffman RM. Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture. Cancer Res 1993; 53: 2479-2483.
6. Benhar M, Dalyot I, Engelberg D, Levitzki A. p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 2001; 21: 6913-6926.
7. Avillard V, Drbal AA, Swaine DJ, Phillips RM, Double JA, Nicolaou A. Analysis of cell-cycle kinetics and sulfur amino acid metabolism in methionine-dependent tumor cell lines; the effect of homocysteine supplementation. Biochem Pharmacol 2004; 67: 1587-99.
8. Lu S, Epner DE. Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells. Nutr Cancer 2000; 38: 123-130.
9. Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, Chollet P. Methionine dependency and cancer treatment. Cancer Treat Rev. 2003; 29: 489-499.
10. Judde JG, Ellis M, Frost P. Biochemical analysis of the role of transmethylation in the MET dependence of tumor cells. Cancer Res 1989; 49: 4859-4865.
11. Poirson-Bichat F, Lopez R, Bras Goncalves RA, Miccoli L, Bourgeois Y, Demerseman P, Poisson M, Dutrillaux B, Poupon MF. Methionine deprivation and methionine analogs inhibit cell proliferation and growth of human xenografted gliomas. Life Sci. 1997; 60: 919-931.
12. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009; 27: 1006-20.
13. Kreis W, Goodenow M. MET requirement replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. Cancer Res 1978; 38: 2259-2262.
14. Cao WX, Ou JM, Fei XF, Zhu ZG, Yin HR, Yan M, Lin YZ. Methionine-dependence and combination chemotherapy on human gastric cancer cells in vitro. World J Gastroenterol 2002; 8: 230-232.
15. Kokkinakis DM, Liu X, Neuner RD. Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. Mol Cancer Ther. 2005; 4: 1338-1348.
16. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011; 147: 275-292.
17. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003; 362: 305-315.
18. Goseki N, Yamazaki S, Endo M, Onodera T, Kosaki G, Hibino Y, Kuwahata T. Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on Yoshida sarcoma-bearing rats. Cancer 1992; 69: 1865-1872.
19. Epner DE. Can dietary methionine restriction increase the effectiveness of chemotherapy in treatment of advanced cancer? J. Am. Coll. Nutr. 2001; 20: 443S-449S.
20. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140: 883-899.
21. Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell 2008; 135: 1161-1163.
22. White E, Karp C, Strohecker AM, Guo Y, Mathew R. Role of autophagy in suppression of inflammation and cancer. Curr. Opin. Cell Biol. 2010; 22: 212-217.
23. Davis CD, Uthus EO. DNA Methylation, Cancer Susceptibility, and Nutrients Interactions. Exp Biol Med (Maywood). 2004; 229: 988-995.
24. Christofori G. The role of the cell-adhesion molecule E-cadherine as a tumor suppressor gene. Trends Biochem Sci 1999; 24; 73-76.
25. Graziano F, Arduini F, Ruzzo A, Mandolesi A, Bearzi I, Silva R, Muretto P, Testa E, Mari D, Magnani M, Scartozzi M, Cascinu S. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs Ann of Onc 2004; 15: 489-492,.
26. Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simöes M. E-Cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 2001; 20: 1525-1528.
27. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ. Cadherine gene promoter hypermethylation in primari human gastric carcinomas, J Natl Cancer Inst 2000; 92: 569-573.
28. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 1990; 59: 237-252.
29. Polakis P. Wnt signalling and cancer. Gene Dev 2000: 14; 1837-1851.